Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

270 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer.
Bertucci F, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G, Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J, Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D, Fert V, Birnbaum D, Viens P. Bertucci F, et al. Among authors: treilleux i. Breast Cancer Res Treat. 2011 Jun;127(2):363-73. doi: 10.1007/s10549-010-1003-z. Epub 2010 Jun 29. Breast Cancer Res Treat. 2011. PMID: 20585850
Calibration of immunohistochemistry for assessment of HER2 in breast cancer: results of the French multicentre GEFPICS study.
Vincent-Salomon A, MacGrogan G, Couturier J, Arnould L, Denoux Y, Fiche M, Jacquemier J, Mathieu MC, Penault-Llorca F, Rigaud C, Roger P, Treilleux I, Vilain MO, Mathoulin-Pélissier S, Le Doussal V. Vincent-Salomon A, et al. Among authors: treilleux i. Histopathology. 2003 Apr;42(4):337-47. doi: 10.1046/j.1365-2559.2003.01598.x. Histopathology. 2003. PMID: 12653945
Breast carcinoma cells promote the differentiation of CD34+ progenitors towards 2 different subpopulations of dendritic cells with CD1a(high)CD86(-)Langerin- and CD1a(+)CD86(+)Langerin+ phenotypes.
Thomachot MC, Bendriss-Vermare N, Massacrier C, Biota C, Treilleux I, Goddard S, Caux C, Bachelot T, Blay JY, Menetrier-Caux C. Thomachot MC, et al. Among authors: treilleux i. Int J Cancer. 2004 Jul 10;110(5):710-20. doi: 10.1002/ijc.20146. Int J Cancer. 2004. PMID: 15146561
Dendritic cell infiltration and prognosis of early stage breast cancer.
Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, Guastalla JP, Bremond A, Goddard S, Pin JJ, Barthelemy-Dubois C, Lebecque S. Treilleux I, et al. Clin Cancer Res. 2004 Nov 15;10(22):7466-74. doi: 10.1158/1078-0432.CCR-04-0684. Clin Cancer Res. 2004. PMID: 15569976
[Neoadjuvant chemotherapy and ovarian cancer].
Ray-Coquard I, Saba C, Bachelot T, Méeus P, Mignotte H, Blondet R, Treilleux I, Peix M, Guastalla JP. Ray-Coquard I, et al. Among authors: treilleux i. Bull Cancer. 2006 Jul;93(7):669-76. Bull Cancer. 2006. PMID: 16873075 Free article. Review. French.
Prognosis of early-onset breast cancer based on BRCA1/2 mutation status in a French population-based cohort and review.
Bonadona V, Dussart-Moser S, Voirin N, Sinilnikova OM, Mignotte H, Mathevet P, Brémond A, Treilleux I, Martin A, Romestaing P, Raudrant D, Rudigoz RC, Lenoir GM, Lasset C. Bonadona V, et al. Among authors: treilleux i. Breast Cancer Res Treat. 2007 Jan;101(2):233-45. doi: 10.1007/s10549-006-9288-7. Epub 2006 Oct 24. Breast Cancer Res Treat. 2007. PMID: 17061047
270 results